• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Innovation spurs novel nontraditional applications

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 30 No 11
Volume 30
Issue 11

The inherent strengths of ultrasound-low cost, wide availability,nonionizing radiation-make this modality a favorite to getthe diagnostic ball rolling.

The inherent strengths of ultrasound-low cost, wide availability, nonionizing radiation-make this modality a favorite to get the diagnostic ball rolling. Technological advances headed for the RSNA exhibit floor will give added impetus to its use, as engineers have tackled some of sonography's most vexing shortfalls: lack of reproducibility from one user to another, and distinguishing anatomical structures.

  • Breast imaging tools. Algorithms and automation bring out details in dense or fatty breasts that may reduce the need to perform biopsies of suspicious lesions found on mammography.

  • Streamlining procedures increases efficiency. Preprogramming and intelligent software ease the tedium of ultrasound scans, reducing key strokes and cutting exam time. A side benefit, greater reproducibility, comes from less dependence on the user's skill set.

  • The power of fusion. The real-time advantages of ultrasound merge with the anatomical clarity provided by CT and MR, raising the potential of greater accuracy during interventions.

-GF

Recent Videos
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.